Duncan McHale
Chief Tech/Sci/R&D Officer bij EVELO BIOSCIENCES, INC.
Vermogen: 764 $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Duncan McHale
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
University of Leeds
79
| College/University | Other Consumer Services | 79 |
Public Company | Pharmaceuticals: Major | 38 | |
The University of Newcastle
34
| College/University | Other Consumer Services | 34 |
33
| Public Company | Pharmaceuticals: Major | 33 |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE.
21
| Subsidiary | Pharmaceuticals: Major | 21 |
Pfizer Ltd.
Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Weatherden Ltd.
Weatherden Ltd. BiotechnologyHealth Technology Weatherden Ltd. is a pioneering clinical development consulting group based in London, UK. The British company specializes in scientific strategy, translational medicine, clinical development, diligence preparation, and support for M & A. Weatherden focuses on de-risking programs early and optimizing clinical, regulatory, and commercial pathways to bring life-changing medicines to patients. With over 750 years of combined industry experience, they are dedicated to improving the chances for breakthrough therapies to address unmet clinical needs. The private company, founded by Duncan McHale and Houman Ashrafian, provides trusted advice to biopharma, funds, startups, spin-outs, and nonprofits. Emma Tinsley has been the CEO of the company since 2017.
2
| Private Company | Biotechnology | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Duncan McHale via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
The Wellcome Trust Ltd.
The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Investment Trusts/Mutual Funds | Director/Board Member Corporate Officer/Principal | |
SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
CODEXIS, INC. | Chemicals: Specialty | Director/Board Member Director/Board Member | |
REALM THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director of Finance/CFO | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Stanford University | College/University | Masters Business Admin Corporate Officer/Principal | |
University of Oxford | College/University | Corporate Officer/Principal Undergraduate Degree | |
Imperial College London | College/University | Doctorate Degree Corporate Officer/Principal | |
University of Cambridge | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Chief Executive Officer Private Equity Investor | |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the private company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Sales & Marketing Chief Operating Officer | |
INSEAD | College/University | Masters Business Admin Masters Business Admin | |
University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
University of Bristol | College/University | Graduate Degree Graduate Degree | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Nanyang Technological University | College/University | Graduate Degree Undergraduate Degree | |
The University of Jordan | College/University | Undergraduate Degree Undergraduate Degree | |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal President | |
King's College London | College/University | Doctorate Degree Corporate Officer/Principal | |
CPA Australia Ltd.
CPA Australia Ltd. Miscellaneous Commercial ServicesCommercial Services CPA Australia Ltd. is an Australian company that has been operating since 1954 and provides education, training, technical support, and advocacy services in the accounting profession. The private company is based in Southbank, Australia and has subsidiaries in Hong Kong. The company engages with governments, regulators, and industries to advocate for policies that stimulate sustainable economic growth. With over 166,000 members working in 100 countries and regions, CPA Australia is one of the world's largest accounting bodies. It was founded in 1886 by Andrew Lyell, Arthur Cleveland, Benjamin Doughty Smith, Thomas Brentnall, John McAlister Howden, Charles Morell Holmes, William Crellin, and Edward Langton. Andrew Paul Hunter has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
FIRST JORDAN INVESTMENT COMPANY PLC | Financial Conglomerates | Director/Board Member Director/Board Member | |
Institute of Singapore Chartered Accountants
Institute of Singapore Chartered Accountants Miscellaneous Commercial ServicesCommercial Services Institute of Singapore Chartered Accountants provides accounting services. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Maven Capital Partners UK LLP
Maven Capital Partners UK LLP Investment ManagersFinance Maven Capital Partners UK LLP (Maven Capital Partners) is a private equity subsidiary of Mattioli Woods PLC founded in 1986. The firm is headquartered in Manchester, United Kingdom. | Investment Managers | Director of Investments Private Equity Investor | |
Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
DIMENSIONS: JORDAN AND EMIRATES COMMERCIAL INVESTMENTS CORPORATION | Real Estate Development | Director/Board Member Corporate Officer/Principal | |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The private company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Financial Conglomerates | Director/Board Member Corporate Officer/Principal | |
UCB Celltech
UCB Celltech BiotechnologyHealth Technology Part of UCB SA, UCB Celltech is a British company that develops novel therapeutic products for humans. The private company is based in Slough, UK and was founded in 2006. | Biotechnology | Director/Board Member Director/Board Member | |
Ameriabank CJSC
Ameriabank CJSC Regional BanksFinance Ameriabank CJSC operates as a commercial bank. It offers corporate, investment and retail banking services. The firm's corporate banking services include financing, small and micro loans, deposits, account opening and services, cards and other financial services. Its investment banking services include mergers and acquisitions, corporate finance, foreign exchange transactions and brokerage. The firm's retail banking services include mortgage loans, car loans, consumer loans and savings account. The company was founded in 1910 and is headquartered in Yerevan, Armenia. | Regional Banks | Director/Board Member Director/Board Member | |
Wallon Institute for Life Lead Sciences | Director/Board Member Director/Board Member | ||
SERES THERAPEUTICS, INC. | Biotechnology | Founder Director of Finance/CFO | |
AXCA HEALPAR | Biotechnology | Chief Executive Officer Founder Chairman | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
CODIAK BIOSCIENCES | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Cygnal Therapeutics, Inc.
Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder Director/Board Member | |
MODERNA, INC. | Biotechnology | Director/Board Member Founder Chief Tech/Sci/R&D Officer | |
RUBIUS THERAPEUTICS | Biotechnology | President Founder Chairman | |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Montai Health, Inc.
Montai Health, Inc. Packaged SoftwareTechnology Services Montai Health, Inc. is a company that is using its pioneering AI-powered Conecta™ platform to develop Anthromolecule™ medicines that will treat and preempt chronic diseases to improve health outcomes for the 2 billion people worldwide living with these diseases. The company is based in Cambridge, MA. Montai Health is unlocking the potential of Anthromolecule™ chemistry with its pioneering AI-powered Conecta™ platform to develop breakthrough small-molecule medicines that will treat and preempt chronic diseases to improve health outcomes for the two billion people worldwide living with these diseases. The company was founded by Hok Hei Tam, Michael Wong, David Kolesky, Mary Margaret Hastings Georgiadis. Mary Margaret Hastings Georgiadis has been the CEO since incorporation. | Packaged Software | Director/Board Member Chairman | |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Founder Chief Executive Officer | |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder Chief Executive Officer |
Statistieken
Internationaal
Verenigde Staten | 26 |
Verenigd Koninkrijk | 13 |
Jordanië | 4 |
Singapore | 3 |
België | 3 |
Sectoraal
Health Technology | 21 |
Consumer Services | 13 |
Commercial Services | 8 |
Finance | 8 |
Miscellaneous | 2 |
Operationeel
Director/Board Member | 468 |
Corporate Officer/Principal | 189 |
Independent Dir/Board Member | 104 |
Chairman | 101 |
Undergraduate Degree | 80 |
Sterkste connecties
Insiders | |
---|---|
Noubar Afeyan | 75 |
Mark McDade | 35 |
Thomas Leysen | 35 |
Thomas Fulton Wilson McKillop | 28 |
David Epstein | 28 |
Stephen Zev Joseph | 28 |
Theo Melas-Kyriazi | 26 |
Alice Dautry-Varsat | 26 |
Soo Chew Loy | 26 |
Ulf Arne Wiinberg | 26 |
Jose-Carlos Gutiérrez-Ramos | 24 |
Harriet Edelman | 22 |
Houman Ashrafian | 22 |
Frederic Roch Doliveux | 21 |
Peter John Fellner | 21 |
- Beurs
- Insiders
- Duncan McHale
- Bedrijfsconnecties